2,300 unvaccinated students may not be allowed back to class, Seattle Public Schools warn

2,300 unvaccinated students may not be allowed back to class, Seattle Public Schools warn

submitted by /u/Fitness_and_Finance [link] [comments]

https://ift.tt/39qWGaf December 30, 2019 at 07:28PM https://ift.tt/1R552o9

2,300 unvaccinated students may not be allowed back to class, Seattle Public Schools warn

submitted by /u/Fitness_and_Finance [link] [comments]

Sol-Gel acne cream reduces marks in late-stage studies, shares soar

Sol-Gel acne cream reduces marks in late-stage studies, shares soar
Reuters: Health
Sol-Gel Technologies Ltd's shares more than tripled in value on Monday after the company said its lead acne drug candidate, Twyneo, met the main goal of reducing marks in two late-stage studies.

301: How to Use Light to Drastically Improve Health With Matt Maruca

301: How to Use Light to Drastically Improve Health With Matt Maruca

I’m here today with Matt Maruca who is a researcher, a teacher, an entrepreneur in the field of photobiology. He founded RA Optics, a company that helps people reach for optimal health through the use of light and blue light protection glasses. After suffering from poor health and chronic fatigue since the age of 14, …

Continue reading 301: How to Use Light to Drastically Improve Health With Matt Maruca...

December 30, 2019 at 04:30PM Wellness Mama® https://ift.tt/2hMTHxr https://ift.tt/eA8V8J

Sol Gel's acne cream reduces marks in late-stage studies

Sol Gel's acne cream reduces marks in late-stage studies
Reuters: Health
Sol Gel Technologies Ltd said on Monday its lead acne drug candidate, Twyneo, met the main goal of reducing marks in two late-stage studies.

China bans imports of pigs from Indonesia due to African swine fever

China bans imports of pigs from Indonesia due to African swine fever
Reuters: Health
China's customs said it has banned imports of pigs, wild boars and related products from Indonesia due to African swine fever.

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer
Reuters: Health
AstraZeneca and Merck's ovarian cancer drug Lynparza has received U.S. regulatory approval for the treatment of advanced pancreatic cancer, cementing its lead in a niche category of cancer treatments.